XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Revenue Recognition (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
item
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
item
contract
Jun. 30, 2020
USD ($)
Disaggregation of Product Revenue        
Practical Expedients, not disclose the value of unsatisfied performance obligations     true  
Number of contracts | contract     2  
Number of specialty pharmacies. | item 2   2  
Number of portfolio of contract | contract     1  
Mytesi        
Disaggregation of Product Revenue        
Product revenue $ 317,000 $ 3,200,000 $ 1,300,000 $ 4,000,000.0
Mytesi | Specialty Pharmacies        
Disaggregation of Product Revenue        
Product revenue 62,000 0 237,000 0
Neonorm        
Disaggregation of Product Revenue        
Product revenue $ 6,000 $ 14,000 $ 39,000 $ 48,000